醫學檢驗生物技術學系

研究成果

每年研究成果 1987 2005 2006 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025

• 884 Article
• 50 Review article
• 35 Conference contribution
• 27 Patent
• 30 更多
  • 15 Comment/debate
  • 7 Letter
  • 5 Chapter
  • 2 Short survey
  • 1 Book

每年研究成果

每年研究成果

搜尋結果

• 2023

  Correction: Akt: a key transducer in cancer (Journal of Biomedical Science, (2022), 29, 1, (76), 10.1186/s12929-022-00860-9)

  Tsai, P. J., Lai, Y. H., Manne, R. K., Tsai, Y. S., Sarbassov, D. & Lin, H. K., 2023 12月, 於: Journal of biomedical science. 30, 1, 7.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Clinical Medicine 100%
  • Transducers 86%
  • Kazakhstan 64%
  • Error 63%
  • Medicine 62%
  2 引文 斯高帕斯（Scopus）

• Erratum: Correction: Zebrafish larvae exposed to ginkgotoxin exhibit seizure-like behavior that is relieved by pyridoxal-5'-phosphate, GABA and anti-epileptic drugs (Disease models & mechanisms (2012) 5 6 (785-795) PII: dmm050550)

  Lee, G. H., Sung, S. Y., Chang, W. N., Kao, T. T., Tu, H. C., Hsiao, T. H., Safo, M. K. & Fu, T. F., 2023 10月 1, 於: DMM Disease Models and Mechanisms. 16, 10

  研究成果: Comment/debate › 同行評審

  開啟存取
• 2022

  Corrigendum to “Multiplex antibacterial processes and risk in resistant phenotype by high oxidation-state nanoparticles: New killing process and mechanism investigations” [Chem. Eng. J. 409 (2021) 128266] (Chemical Engineering Journal (2021) 409, (S1385894720343783), (10.1016/j.cej.2020.128266))

  Hsu, I. L., Yeh, F. H., Chin, Y. C., Cheung, C. I., Chia, Z. C., Yang, L. X., Chen, Y. J., Cheng, T. Y., Wu, S. P., Tsai, P. J., Lee, N. Y., Liao, M. Y. & Huang, C. C., 2022 1月 15, 於: Chemical Engineering Journal. 428, 131957.

  研究成果: Comment/debate › 同行評審

  • chemical engineering 100%
  • Chemical Engineering 99%
  • Chemical engineering 97%
  • phenotype 90%
  • Nanoparticles 81%
• 2021

  Corrigendum: The Role of Toll-Like Receptor-2 in Clostridioides difficile Infection: Evidence From a Mouse Model and Clinical Patients (Front. Immunol., (2021), 12, (691039), 10.3389/fimmu.2021.691039)

  Lai, Y. H., Tsai, B. Y., Hsu, C. Y., Chen, Y. H., Chou, P. H., Chen, Y. L., Liu, H. C., Ko, W. C., Tsai, P. J. & Hung, Y. P., 2021 12月 8, 於: Frontiers in Immunology. 12, 803805.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Toll-Like Receptor 2 100%
  • Medicine 57%
  • Infections 37%
  2 引文 斯高帕斯（Scopus）
• 2019

  Corrigendum: The ATP-P2X₇ signaling axis is an essential sentinel for intracellular Clostridium difficile pathogen-induced inflammasome activation (Front. Cell. Infect. Microbiol., (2018) 8, 10.3389/fcimb.2018.00084)

  Liu, Y. H., Chang, Y. C., Chen, L. K., Su, P. A., Ko, W. C., Tsai, Y. S., Chen, Y. H., Lai, H. C., Wu, C. Y., Hung, Y. P. & Tsai, P. J., 2019, 於: Frontiers in Cellular and Infection Microbiology. 9, JUL, 260.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Inflammasomes 100%
  • Clostridium difficile 99%
  • Adenosine Triphosphate 64%
  • Medicine 60%
  2 引文 斯高帕斯（Scopus）

• Erratum: A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth (Cancer Research (2005) 65 (4827–4835) DOI: 10.1158/0008-5472.CAN-05-0188)

  Su, J. L., Lai, K. P., Chen, C. A., Yang, C. Y., Chen, P. S., Chang, C. C., Chou, C. H., Hu, C. L., Kuo, M. L., Hsieh, C. Y. & Wei, L. H., 2019, 於: Cancer Research. 79, 14, p. 3791 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Interleukin-6 Receptors 100%
  • Western Blotting 52%
  • Peptides 48%
  • Growth 38%
  • Actins 32%
  1 引文 斯高帕斯（Scopus）

• Erratum: Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1 (Cancer Research (2009) 69 (3482–3491) DOI: 10.1158/0008-5472.CAN-08-2524)

  Wang, M. Y., Chen, P. S., Prakash, E., Hsu, H. C., Huang, H. Y., Lin, M. T., Chang, K. J. & Kuo, M. L., 2019, 於: Cancer Research. 79, 14, p. 3792 1 p.

  研究成果: Comment/debate › 同行評審

  • Connective Tissue Growth Factor 100%
  • Drug Resistance 69%
  • Western Blotting 51%
  • Tubulin 40%
  • Neoplasms 24%
• 2017

  Correction for Cairns et al., Comparative genome analysis and global phylogeny of the toxin variant Clostridium difficile PCR ribotype 017 reveals the evolution of two independent sublineages (Journal of Clinical Microbiology (2017) 55:3 (865-876) DOI: 10.1128/JCM.01296-16)

  Cairns, M. D., Preston, M. D., Hall, C. L., Gerding, D. N., Hawkey, P. M., Kato, H., Kim, H., Kuijper, E. J., Lawley, T. D., Pituch, H., Reid, S., Kullin, B., Riley, T. V., Solomon, K., Tsai, P. J., Weese, J. S., Stabler, R. A. & Wren, B. W., 2017 6月, 於: Journal of Clinical Microbiology. 55, 6, p. 1971 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取

  • Ribotyping 100%
  • Phylogeny 85%
  • Clostridium difficile 84%
  • Republic of Korea 84%
  • Singapore 82%
  2 引文 斯高帕斯（Scopus）

• Erratum: miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans (The Journal of clinical investigation (2011) 121 9 (3442-3455) PII: 92099)

  Chen, P. S., Su, J. L., Cha, S. T., Tarn, W. Y., Wang, M. Y., Hsu, H. C., Lin, M. T., Chu, C. Y., Hua, K. T., Chen, C. N., Kuo, T. C., Chang, K. J., Hsiao, M., Chang, Y. W., Chen, J. S., Yang, P. C. & Kuo, M. L., 2017 3月 1, 於: The Journal of clinical investigation. 127, 3, 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
  6 引文 斯高帕斯（Scopus）

• Erratum: Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility (The Journal of clinical investigation (2013) 123 3 (1082-1095) PII: 91882)

  Kuo, T. C., Tan, C. T., Chang, Y. W., Hong, C. C., Lee, W. J., Chen, M. W., Jeng, Y. M., Chiou, J., Yu, P., Chen, P. S., Wang, M. Y., Hsiao, M., Su, J. L. & Kuo, M. L., 2017 1月 3, 於: The Journal of clinical investigation. 127, 1, p. 402 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）
• 2015

  A cascade of protein aggregation bombards mitochondria for neurodegeneration and apoptosis under WWOX deficiency

  Sze, C. I., Kuo, Y. M., Hsu, L. J., Fu, T. F., Chiang, M. F., Chang, J. Y. & Chang, N. S., 2015 9月 10, 於: Cell Death and Disease. 6, 9, e1881.

  研究成果: Comment/debate › 同行評審

  開啟存取
  17 引文 斯高帕斯（Scopus）
• 2014

  Correction: Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma

  Lee, Y. K., Lin, T. H., Chang, C. F. & Lo, Y. L., 2014 9月 8, 於: PloS one. 9, 9, e107784.

  研究成果: Comment/debate › 同行評審

  開啟存取
• 2009

  Erratum: Functional nanoparticle-based proteomic strategies for characterization of pathogenic bacteria (Analytical Chemistry (2008) 80 (9612-9621))

  Chen, W. J., Tsai, P. J. & Chen, Y. C., 2009 2月 15, 於: Analytical Chemistry. 81, 4, p. 1722 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
  2 引文 斯高帕斯（Scopus）
• 2004

  Erratum: Discovery of picomolar slow tight-binding inhibitors of α-fucosidase (Chemistry and Biology (2004) (1301-1306))

  Chang, C. F., Ho, C. W., Wu, C. Y., Chao, T. A., Wong, C. H. & Lin, C. H., 2004 11月, 於: Chemistry and Biology. 11, 11, p. 1595 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
• 2002

  Erratum: Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide. (Journal of Immunology (2002) 169 (657-664))

  Lin, C. F., Lei, H. Y., Shiau, A. L., Liu, H. S., Yeh, T. M., Chen, S. H., Liu, C. C., Chiu, S. C. & Lin, Y. S., 2002 8月 15, 於: Journal of Immunology. 169, 4, p. 2215 1 p.

  研究成果: Comment/debate › 同行評審

  開啟存取
  1 引文 斯高帕斯（Scopus）